AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.
Zhu C, Wei Y, Wei X. · 2019
Read AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. by Zhu C, Wei Y, Wei X. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6827209.txt.
Introduction
Zhu and co-authors review a cell-surface receptor called AXL in Molecular Cancer. AXL belongs to the TAM family of receptors. Its partner protein, GAS6, switches it on. In many cancers AXL is overactive. That activity helps tumours grow, spread, and survive treatment.
The review lays out AXL's structure, its normal roles, and the signals it sends. Those signals aid invasion, new blood vessel growth, and the shift of cells into a mobile state. They also help cancers resist drugs and hide from the immune system. The authors then survey attacks on AXL now in study, from small-molecule blockers and antibodies to aptamers and natural compounds.
Catalog record
| CREATOR | Zhu C, Wei Y, Wei X. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 114 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |